GlassScriptPhysician profile
Kari Sierant
NPI 1184149940
$9,417.52
in general payments reported to CMS, 2019-2025
51 companies · $1,113 in 2025
The $1,113 reported for 2025 was more than what 86% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $729 · 2022: $888 · 2023: $3,897 · 2024: $2,790 · 2025: $1,113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,640 · Food and Beverage: $2,869 · Education: $292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,640.00 |
| Food and Beverage | $2,868.70 |
| Education | $291.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $5,017.30 | 2021-2025 | Darzalex, Tecvayli, Carvykti |
| Abbvie INC. | $420.18 | 2021-2025 | |
| Incyte Corporation | $384.44 | 2021-2025 | Jakafi |
| Pfizer INC. | $293.06 | 2022-2025 | |
| Glaxosmithkline, LLC. | $266.59 | 2021-2025 | Zejula, Jemperli, Ojjaara |
| Amgen INC. | $262.82 | 2021-2023 | Blincyto |
| Astrazeneca Pharmaceuticals LP | $250.85 | 2022-2025 | Lynparza, Enhertu, Tagrisso |
| Novartis Pharmaceuticals Corporation | $236.45 | 2023-2025 | |
| Seagen INC. | $179.60 | 2021-2023 | Tukysa, Adcetris |
| Bayer Healthcare Pharmaceuticals INC. | $160.49 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $151.55 | 2021-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Takeda Pharmaceuticals U.S.A., INC. | $147.79 | 2022-2025 | Ninlaro, Alunbrig, Iclusig |
| Genentech USA, INC. | $121.84 | 2022-2024 | Tecentriq, Alecensa, Polivy |
| Taiho Oncology, INC. | $117.95 | 2023-2025 | |
| Rigel Pharmaceuticals, INC. | $92.42 | 2021-2025 | Rezlidhia, Tavalisse, Gavreto |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genmab U.S., INC. | $80.52 | 2022-2025 | Epkinly, Tivdak |
| Eisai INC. | $79.26 | 2021-2024 | |
| Lilly USA, LLC | $73.45 | 2022-2025 | Verzenio, Jaypirca, Retevmo |
| Cti Biopharma Corp. | $73.08 | 2022-2023 | Vonjo |
| Celgene Corporation | $61.28 | 2022-2023 | Pomalyst |
| Astellas Pharma US INC | $61.03 | 2021-2023 | Xospata |
| Daiichi Sankyo INC. | $57.90 | 2021-2025 | Enhertu |
| Kite Pharma, INC. | $56.87 | 2021-2023 | Yescarta |
| Janssen Pharmaceuticals, INC | $52.66 | 2021-2023 | Xarelto |
| Beigene USA, INC. | $52.22 | 2023-2024 | Brukinsa |
| Regeneron Healthcare Solutions, INC. | $49.73 | 2021-2024 | Libtayo |
| Myriad Genetic Laboratories, INC. | $49.26 | 2023 | Precisetumor |
| Jazz Pharmaceuticals INC. | $45.62 | 2021-2024 | |
| Blueprint Medicines Corporation | $37.34 | 2023-2024 | Ayvakit |
| Geron Corporation | $36.83 | 2025 | Rytelo |
| Alexion Pharmaceuticals, INC. | $32.84 | 2022-2024 | Ultomiris |
| Genzyme Corporation | $32.61 | 2023-2025 | |
| Sobi, INC | $32.53 | 2024-2025 | |
| Pharmacosmos Therapeutics INC. | $31.30 | 2022-2024 | Monoferric |
| Emd Serono, INC. | $30.62 | 2023-2025 | Tepmetko |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.61 | 2022-2023 | Gilotrif |
| Acceleron Pharma, INC. | $29.05 | 2021 | |
| Mirati Therapeutics, INC. | $20.47 | 2024 | Krazati |
| Tempus Ai, INC | $18.79 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $18.39 | 2025 | Opdivo |
| Pharmaessentia USA Corporation | $18.10 | 2025 | Besremi |
| Servier Pharmaceuticals LLC | $18.06 | 2025 | |
| Agios Pharmaceuticals, INC. | $17.98 | 2025 | Pyrukynd |
| Deciphera Pharmaceuticals INC. | $17.04 | 2025 | Qinlock, Romvimza |
| Morphosys, US INC. | $16.19 | 2022 | |
| Stemline Therapeutics INC. | $15.22 | 2025 | Orserdu |
| Welch Allyn | $14.55 | 2021 | |
| Immunogen, INC. | $13.82 | 2023 | Elahere |
| Pharmacyclics LLC, An Abbvie Company | $13.35 | 2022 | |
| Baxter Healthcare | $13.23 | 2022 | |
| Heron Therapeutics, INC. | $12.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kari Sierant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.